By BISHAL GYAWALI MD Keynote speech There was a very sobering piece in NEJM by the FDA last month in which the authors try to explore what went wrong with the Keynote-183, Keynote-185 and checkmate 602 trials testing PD-1 inhibitors combinations with
Read More...
Read the complete post at http://thehealthcareblog.com/blog/2018/12/17/last-month-in-oncology-with-dr-bishal-gyawali-november-2018/
Posted
Dec 17 2018, 06:49 AM
by
THCB